Mechanisms that regulate silencing of gene expression from retroviral vectors.
The propensity of retroviruses toward transcriptional silencing limits their value as gene therapy vectors. Silencing has been shown to be particularly robust when stem cells are used for transduction, posing a significant problem for gene therapy of hematologic diseases. Stability of proviral expression with newer generation vectors is significantly improved over that obtainable with original vectors based on Moloney murine leukemia virus (MoMLV). However, strategies to increase resistance further to retroviral silencing are needed, because newer generation vectors have been shown to remain prone to a significant degree of silencing that could limit their efficacy as gene therapy vectors. Proviral silencing has been attributed to known mechanisms of cellular gene repression, such as DNA methylation and histone modification, as well as uncharacterized mechanisms that act independently of DNA methylation. A further understanding of transcriptional silencing that occurs in stem cells and during hematopoietic development is needed for design of effective vectors for gene therapy of hematologic diseases.
Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294-3300, USA.
C Scott
CS
Swindle
Christopher A
CA
Klug
D000818:Animals; D015967:Gene Expression Regulation, Viral; D020868:Gene Silencing; D015316:Genetic Therapy / Q000592:standards; D005822:Genetic Vectors / Q000009:adverse effects / Q000235:genetics*; D006801:Humans; D012190:Retroviridae / Q000235:genetics*; D014158:Transcription, Genetic; D014161:Transduction, Genetic / Q000592:standards